Provided by Tiger Fintech (Singapore) Pte. Ltd.

Penumbra

269.77
-7.5850-2.73%
Volume:181.40K
Turnover:49.31M
Market Cap:10.44B
PE:749.35
High:278.59
Open:278.06
Low:268.85
Close:277.35
Loading ...

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

Zacks
·
30 Nov 2024

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

Zacks
·
30 Nov 2024

Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

Zacks
·
29 Nov 2024

Reasons to Retain Medtronic Stock in Your Portfolio Now

Zacks
·
29 Nov 2024

QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site

Zacks
·
29 Nov 2024

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

Zacks
·
28 Nov 2024

QGEN Stock Dips Despite Launch of Customized dPCR Assay Design Tools

Zacks
·
28 Nov 2024

Is it the Right Time to Hold Charles River Stock in Your Portfolio?

Zacks
·
28 Nov 2024

Hologic to Debut AI-Powered Innovations at RSNA 2024: Stock to Gain?

Zacks
·
28 Nov 2024

Leerink Partners Sticks to Their Buy Rating for Penumbra (PEN)

TIPRANKS
·
28 Nov 2024

New Alliances to Support STERIS Stock Despite Macro Issues

Zacks
·
27 Nov 2024

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

Zacks
·
27 Nov 2024

ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee

Zacks
·
26 Nov 2024

BSX Stock Set to Gain From Agreement to Acquire Intera Oncology

Zacks
·
26 Nov 2024

Penumbra price target raised to $270 from $232 at BTIG

TIPRANKS
·
26 Nov 2024

Cautious Hold Recommendation Amid Uncertainty Following FDA Clearance of Penumbra’s Element Vascular Access System

TIPRANKS
·
26 Nov 2024

Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved Technologies

Insider Monkey
·
26 Nov 2024

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain

Zacks
·
25 Nov 2024

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Zacks
·
25 Nov 2024

Reasons to Retain IART Stock in Your Portfolio for Now

Zacks
·
25 Nov 2024